Blood test could quickly predict if the drug palbociclib will help breast cancer patients
(Medical Research Council) A new study has found a blood test for cancer DNA could predict if a woman is responding to the breast cancer drug palbociclib, months earlier than current tests. Scientists from The Institute of Cancer Research, London, say the test could detect in two to three weeks whether the drug is working, although they caution the results need replicating before they are used clinically. The research was funded by the Medical Research Council. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 1, 2018 Category: International Medicine & Public Health Source Type: news

Longer breast cancer monitoring & quot;financially viable & quot; in Mexico
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2018 Category: Drugs & Pharmacology Source Type: news

Concerns Over Texting Medical Orders: Clin Onc News Report
(MedPage Today) -- Also, breast cancer centers focus on survivorship care programs (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 28, 2018 Category: Neurology Source Type: news

Elementary school principal uses strength from students to battle breast cancer
Patricia Cook got some help to fight through one of her toughest battles. (Source: ABC News: Health)
Source: ABC News: Health - February 28, 2018 Category: Consumer Health News Tags: Health Source Type: news

24 unknown mutations increase breast cancer risk
The University of Melbourne team claim their findings could allow doctors to better estimate a woman's risk of getting breast cancer, if the disease has run in her family. (Source: the Mail online | Health)
Source: the Mail online | Health - February 28, 2018 Category: Consumer Health News Source Type: news

Heart failure risk increases for breast cancer, lymphoma survivors
Breast cancer and lymphoma survivors are up to three times more likely to develop congestive heart failure, according to research at the Mayo Clinic. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 28, 2018 Category: Consumer Health News Source Type: news

Heart failure risk higher for some breast cancer survivors
Patients who were treated for breast cancer or lymphoma are more than three times at risk for developing congestive heart failure, compared with other women, according to US researchers. (Source: Nursing Times)
Source: Nursing Times - February 28, 2018 Category: Nursing Source Type: news

A Mixed Picture: An Inquiry into Geographical Inequalities and Breast Cancer
The report shows that, depending on where they live in England, some women are more than twice as likely to die from breast cancer under the age of 75. It calls on NHS England and Public Health England to address these inequalities through better workforce planning and data collection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 28, 2018 Category: Consumer Health News Source Type: news

Familial breast cancer not only inherited genetically, finds new study
(University of Melbourne) Doctors will be better able to predict breast cancer risk thanks to pioneering work led by University of Melbourne researchers, who have identified heritable but non-genetic markers for breast cancer susceptibility. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 28, 2018 Category: International Medicine & Public Health Source Type: news

Breast cancer and lymphoma treatments save lives, but may make heart failure more likely for some
(American College of Cardiology) Patients with a history of breast cancer or lymphoma were more than three times as likely to develop heart failure--a condition in which the heart can't pump enough blood to meet the body's needs -- compared with a similar group of patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific Session. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 28, 2018 Category: International Medicine & Public Health Source Type: news

Geographical inequalities and breast cancer
A report from a breast cancer charity finds that while more women are surviving breast cancer than ever before, stark geographical inequalities exist across England in screening, early detection and access to treatment and services. (Source: NHS Networks)
Source: NHS Networks - February 28, 2018 Category: UK Health Source Type: news

Densitas gets Australian clearance for breast density software
The Australian Therapeutic Goods Administration has granted medical software...Read more on AuntMinnie.comRelated Reading: Densitas highlights study in Breast Cancer Research Densitas deploys breast density software throughout Canada Densitas touts breast density clinical research Densitas accepted into JLABS @ Toronto Densitas highlights breast density research at ECR (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 27, 2018 Category: Radiology Source Type: news

Lilly Breast Cancer Drug Wins Expanded U.S. Approval Lilly Breast Cancer Drug Wins Expanded U.S. Approval
U.S. regulators have approved expanded use of Eli Lilly and Co's Verzenio breast cancer drug as an initial treatment for certain women with advanced or metastatic disease, a decision that should boost sales of the medicine, the company said on Monday.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2018 Category: Consumer Health News Tags: Medscape Today News Alert Source Type: news

Earliest Picture Of Breast Cancer Discovered In A Renaissance Painting
Scientists have discovered early images of malignant breast cancer in Renaissance oil paintings by two Italian artists (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 27, 2018 Category: Pharmaceuticals Authors: Helen Thomson, Contributor Source Type: news

First Comparison of Breast Cancer Tests Finds Variability First Comparison of Breast Cancer Tests Finds Variability
A comparison across six breast cancer tests shows variability in prognostic information. Of the four tests that are commercially available, prognostic significance was lowest with the Oncotype Dx.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Postcode lottery: Some women are twice as likely to die from breast cancer
A POSTCODE lottery of care means some women are more than twice as likely to die from breast cancer depending on where they live. (Source: Daily Express - Health)
Source: Daily Express - Health - February 27, 2018 Category: Consumer Health News Source Type: news

Breast cancer patients doubly likely to die in some areas
Patients in Newark and Sherwood Clinical Commissioning Group, Nottinghamshire, are twice as likely to die from breast cancer as those in Tower Hamlets CCG in east London. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2018 Category: Consumer Health News Source Type: news

Breast Cancer Radiation Not as Bad as Many Fear
Title: Breast Cancer Radiation Not as Bad as Many FearCategory: Health NewsCreated: 2/26/2018 12:00:00 AMLast Editorial Review: 2/27/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 27, 2018 Category: Cancer & Oncology Source Type: news

Race, Insurance Key to Employment After Breast Cancer Diagnosis
Title: Race, Insurance Key to Employment After Breast Cancer DiagnosisCategory: Health NewsCreated: 2/26/2018 12:00:00 AMLast Editorial Review: 2/27/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 27, 2018 Category: Cancer & Oncology Source Type: news

Switching on survival signalling to drive drug resistance
(Queen Mary University of London) Researchers at Queen Mary University of London have discovered that the loss of a single protein- PHLDA1- is sufficient for the development of drug resistance to a type of targeted therapy in endometrial and HER2-positive breast cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 27, 2018 Category: Cancer & Oncology Source Type: news

Wig Master Merria Dearman Helps Cancer Patients
New hair provides self-esteem and hope to cancer patients. by Gatwiri Muthara, AARP, February 26, 2018. Merria Dearman works with a wig client. Courtesy Merria Dearman. Merria Dearman prepares a wig for client Annie Goodman, who had triple negative breast cancer and brain tumors. Goodman lost her cancer battle  ... (Source: AARP.org News)
Source: AARP.org News - February 27, 2018 Category: American Health Source Type: news

Race, Insurance Key to Employment After Breast Cancer Diagnosis
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - February 27, 2018 Category: Cancer & Oncology Source Type: news

Lilly breast cancer drug wins expanded U.S. approval
(Reuters) - U.S. regulators have approved expanded use of Eli Lilly and Co's Verzenio breast cancer drug as an initial treatment for certain women with advanced or metastatic disease, a decision that should boost sales of the medicine, the company said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - February 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Many women fear and misunderstand breast cancer radiation
(Reuters Health) - Women with breast cancer are often afraid of getting radiation, but a new study of women who ’ve had this treatment suggests their experiences with it were much better than they expected. (Source: Reuters: Health)
Source: Reuters: Health - February 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Lilly Receives Additional FDA Approval for Verzenio (abemaciclib), as Initial Treatment for Advanced Breast Cancer
INDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) in combination with an aromatase inhibitor (AI) as initial... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 26, 2018 Category: Drugs & Pharmacology Source Type: news

Breast Cancer Radiation Not as Bad as Many Fear
The study of more than 300 women who underwent breast radiation found that almost half had heard "frightening" stories going into treatment. But only 2 percent ultimately agreed that the stories were true. (Source: WebMD Health)
Source: WebMD Health - February 26, 2018 Category: Consumer Health News Source Type: news

Breast Cancer Radiation Not as Bad as Many Fear
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 26, 2018 Category: Psychiatry Tags: Gynecology, Nursing, Oncology, Pharmacy, Psychiatry, News, Source Type: news

Race, Insurance Key to Employment After Breast Cancer Diagnosis
MONDAY, Feb. 26, 2018 -- Women who leave the workforce after a breast cancer diagnosis are likely to be black or to have public health insurance or none at all, a new study finds. In fact, the study found that black women were four times more... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 26, 2018 Category: General Medicine Source Type: news

Breast Cancer Radiation Not as Bad as Many Fear
MONDAY, Feb. 26, 2018 -- Many breast cancer patients say they've heard scary stories about radiation therapy, but their actual experience is usually better, new research finds. The study of more than 300 women who underwent breast radiation found... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 26, 2018 Category: General Medicine Source Type: news

Half-hour 'blast' sees off breast cancer for good
Thousands of British women could soon benefit from a new breast cancer ‘blaster’ that spares them the ordeal of daily radiotherapy after surgery according to new NHS guidelines. (Source: the Mail online | Health)
Source: the Mail online | Health - February 26, 2018 Category: Consumer Health News Source Type: news

Exposure to common THM levels in drinking water not associated with breast cancer
(Barcelona Institute for Global Health (ISGlobal)) Exposure to trihalomethanes (THMs) in residential water is not associated with an increased risk of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2018 Category: Cancer & Oncology Source Type: news

Most breast cancer patients' experiences with radiation therapy are better than expected
(Wiley) A new study reveals that many patients with breast cancer have misconceptions and fears about radiation therapy, but their actual experiences with modern breast radiation therapy are better than they expected. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 26, 2018 Category: International Medicine & Public Health Source Type: news

Breast Cancer Radiation Not as Bad as Many Fear
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - February 26, 2018 Category: Cancer & Oncology Source Type: news

Nigeria:'15,000 Nigerian Women Die Annually From Breast Cancer'
[Daily Trust] About 15, 000 women in the country die of breast cancer annually, a medical oncologist, specialized in breast cancer, Dr Bisi Ademuyiwa has said. She disclosed this yesterday during a seminar organized by AXA Mansard HMO in collaboration with the African Women's Entrepreneurship Program (AWEP) in Abuja. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 24, 2018 Category: African Health Source Type: news

Europe Says No to Neratinib for Breast Cancer Europe Says No to Neratinib for Breast Cancer
The European committee recommended against approval of neratinib (Nerlynx) for breast cancer, even though the drug has been approved in the United States.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

WATCH: Woman becomes sister's surrogate
Erin Silverman carried a baby for her sister, Randi Fishman, who was diagnosed with breast cancer at age 28. (Source: ABC News: Health)
Source: ABC News: Health - February 23, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Woman becomes sister’s surrogate after breast cancer diagnosis
Randi Fishman was diagnosed with breast cancer at age 28 and didn't think she would ever have kids. (Source: ABC News: Health)
Source: ABC News: Health - February 23, 2018 Category: Consumer Health News Tags: GMA Source Type: news

EU panel recommends against nod for Puma Biotech's breast cancer drug
(Reuters) - A European Medicines Agency (EMA) panel on Friday recommended against approving Puma Biotechnology's lead breast cancer drug, an outcome the U.S drugmaker had signaled last month. (Source: Reuters: Health)
Source: Reuters: Health - February 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Woman becomes sister ’s surrogate after cancer diagnosis 
Erin Silverman, 35, of Potomac, Maryland, became a surrogate after her sister, Randi Fishman, 34, was diagnosed with breast cancer. Erin gave birth to her sister's baby in December. (Source: the Mail online | Health)
Source: the Mail online | Health - February 22, 2018 Category: Consumer Health News Source Type: news

Fathers Can Pass Ovarian Cancer Risk To Their Daughters
BOSTON (CBS) – A new study finds that a higher risk of ovarian cancer can be passed from father to daughter. Researchers at the Roswell Park Cancer Institute in Buffalo, NY looked at data from the Familial Ovarian Cancer Registry and discovered a genetic mutation passed from a father to his daughter on the X-chromosome that puts her at higher risk for ovarian cancer. The research team is looking for what the Ovarian Cancer gene looks like. (WBZ-TV) When we think of hereditary ovarian cancer, we often think of the BRCA genes that raise the risk of both ovarian cancer and breast cancer in first degree female relatives,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Seen On WBZ-TV Syndicated Local Cancer Risk Dr. Mallika Marshall Genes ovarian cancer Source Type: news

Breast Cancer Survivors: Transition to PCP Leads to Savings Breast Cancer Survivors: Transition to PCP Leads to Savings
Transitioning breast cancer survivors from management by an oncologist to PCP was shown to use fewer health system costs and resources.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Sudan:Breast Cancer International Conference to Kick Off in Khartoum Friday
[SNA] Khartoum -The Breast Cancer International Conference will take place in in the Friendship Hall in Khartoum Friday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 22, 2018 Category: African Health Source Type: news

Breast cancer symptoms: Men can test for a cancerous lump using these eight steps
BREAST cancer is usually associated with women, but in rare cases, men can get it too. So how can men test for a cancerous lump? Look out for these signs and symptoms and follow these eight steps. (Source: Daily Express - Health)
Source: Daily Express - Health - February 22, 2018 Category: Consumer Health News Source Type: news

Ask How Does Breast Cancer Start
How Does Breast Cancer Start? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 22, 2018 Category: General Medicine Source Type: news

Impact of 70-Gene Signature Use on Chemo Decisions in BC Impact of 70-Gene Signature Use on Chemo Decisions in BC
Do results of gene-expression profiles change whether patients with ER-positive breast cancer receive adjuvant chemotherapy?Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

ER-Negative Isolated Locoregional Recurrence Benefits From Chemotherapy
Patients with ER-negative, but not ER-positive, isolated locoregional recurrence after unilateral breast cancer derive significant benefit from chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - February 22, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news

YouTuber dies of cancer after claiming veganism cured it
Mari Lopez, who ran the food channel at home in Houston, Texas with her niece Liz Johnson, told viewers she had rejected traditional treatment for breast cancer in favor of a 90-day juice cleanse. (Source: the Mail online | Health)
Source: the Mail online | Health - February 21, 2018 Category: Consumer Health News Source Type: news

Online Tool Aids Decision Making About Breast Cancer Treatment
Findings based on assessment of the interactive iCanDecide tool (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 21, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news

Densitas highlights study in Breast Cancer Research
Medical software developer Densitas is directing attention to a recent review...Read more on AuntMinnie.comRelated Reading: Densitas deploys breast density software throughout Canada Densitas touts breast density clinical research Densitas accepted into JLABS @ Toronto Densitas highlights breast density research at ECR Densitas receives CE Mark, Canadian clearance (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 21, 2018 Category: Radiology Source Type: news

'Local environment' plays key role in breast cancer progression
(Biophysical Society) Many of the drugs and therapies available today for treating breast cancer target the cancer cells but tend to neglect the surrounding 'local environment,' which includes surrounding tissues. But cancer cells and their local environment are connected, so both undergo chemical and physical changes during tumor development. During the 62nd Biophysical Society Meeting, researchers will present work exploring the role physical changes within a cancer cells' local environment play in the aggressiveness of breast cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 21, 2018 Category: Biology Source Type: news